Combination chemotherapy with intermittent erlotinib and pemetrexed for pretreated patients with advanced non-small cell lung cancer: a phase I dose-finding study

BACKGROUND: Erlotinib and pemetrexed have been approved for the second-line treatment of non-small cell lung cancer (NSCLC). These two agents have different mechanisms of action. Combined treatment with erlotinib and pemetrexed could potentially augment the antitumor activity of either agent alone....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Minami, Seigo, Kijima, Takashi, Takahashi, Ryo, Kida, Hiroshi, Nakatani, Takeshi, Hamaguchi, Masanari, Takeuchi, Yoshiko, Nagatomo, Izumi, Yamamoto, Suguru, Tachibana, Isao, Komuta, Kiyoshi, Kawase, Ichiro
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2012
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3437193/
https://ncbi.nlm.nih.gov/pubmed/22809298
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-12-296
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados